Jazz Pharmaceuticals plc (JAZZ) › EPS (Basic)Jazz Pharmaceuticals plc (JAZZ) — EPS (Basic)Annual figures by period end, from SEC filings.2009-12-31: $-0.232010-12-31: $0.902011-12-31: $3.012012-12-31: $5.092013-12-31: $3.712014-12-31: $0.982015-12-31: $5.382016-12-31: $6.562017-12-31: $8.132018-12-31: $7.452019-12-31: $9.222020-12-31: $4.282021-12-31: $-5.522022-12-31: $-3.582023-12-31: $6.552024-12-31: $9.062025-12-31: $-5.84$-5.842009-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-5.84-164.5%2026-02-24From 2025-01-012024-12-31$9.06+38.3%2026-02-24From 2024-01-012023-12-31$6.55—2026-02-24From 2023-01-012022-12-31$-3.58—2025-02-26From 2022-01-012021-12-31$-5.52-229.0%2024-02-28From 2021-01-012020-12-31$4.28-53.6%2023-03-01From 2020-01-012019-12-31$9.22+23.8%2022-03-01From 2019-01-012018-12-31$7.45-8.4%2021-02-23From 2018-01-012017-12-31$8.13+23.9%2020-02-25From 2017-01-012016-12-31$6.56+21.9%2019-02-26From 2016-01-012015-12-31$5.38+449.0%2018-02-27From 2015-01-012014-12-31$0.98-73.6%2017-02-28From 2014-01-012013-12-31$3.71-27.1%2016-02-23From 2013-01-012012-12-31$5.09+69.1%2015-02-24From 2012-01-012011-12-31$3.01+234.4%2014-02-25From 2011-01-012010-12-31$0.90—2013-02-26From 2010-01-012009-12-31$-0.23—2012-02-28From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares